Filing Details

Accession Number:
0001225208-10-021288
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-09-22 16:29:41
Reporting Period:
2010-09-20
Filing Date:
2010-09-22
Accepted Time:
2010-09-22 16:29:41
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
885725 Boston Scientific Corp BSX Surgical & Medical Instruments & Apparatus (3841) 042695240
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
901458 M Peter Nicholas One Boston Scientific Place
Natick MA 01760-1537
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2010-09-20 25,000 $5.47 6,181,021 No 4 S Indirect By Ltd. Partnership
Common Stock Disposition 2010-09-20 125,000 $0.00 6,056,021 No 4 J Indirect By Ltd. Partnership
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By Ltd. Partnership
No 4 J Indirect By Ltd. Partnership
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Forward Sale Contract (obligation to sell) Disposition 2010-09-20 125,000 $0.00 125,000 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2011-09-19 2011-09-19 No 4 J Indirect
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 9,212,125 Direct
Common Stock 2,413,088 Indirect By Trust 2
Footnotes
  1. Sales reported on this form were transacted pursuant to a 10b5-1 trading plan.
  2. Weighted average sales price reported as stock sales were aggregated for reporting purposes. The per share transaction price ranged from $5.55 to $5.40. The reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.
  3. On August 26, 2009, a family limited partnership of which the reporting person is a general and limited partner, Promerica LP, entered into a Rule 10b5-1 trading plan with an unaffiliated bank to execute a series of variable prepaid forward sale contracts. On September 20, 2010, Promerica settled a prepaid variable contract originally entered into on September 18, 2009. At the initiation of the contract, the bank paid $1,100,294.10 to the reporting person.
  4. Under the contract reported on this form, Promerica was obligated to deliver to the bank up to 125,000 shares of the Issuer?s common stock depending on the market price at maturity on September 19, 2011. In addition, if the market price per share was equal to or greater than $13.137 on the first anniversary of the contract date, the bank would be obligated to pay an additional amount, determined by the bank based on the stock price at the time, to Promerica three business days after the first anniversary. If the market price per share on the first anniversary of the contract date was less than $13.137 the contract would then be terminated and Promerica would deliver shares to the bank pursuant to the early termination provision in the contract.
  5. Upon early termination, if the market price per share was equal to or less than $10.9482 Promerica would deliver 125,000 shares to the bank and if the market price per share was greater than $10.9482, Promerica would deliver a fewer number of shares. The closing market price per share on September 20, 2010 was $5.54. Accordingly, Promerica transferred to the bank 125,000 shares of the Issuer?s common stock.
  6. Shares held by a trust of which the reporting persons spouse and brother are trustees and the reporting person's spouse and children are beneficiaries.